AGX814

SARS-Cov-2 Nucleoprotein (aa 1-419) Recombinant Antigen, 616

suitable for ELISA

• Sinônimo(s): 2019-nCoV, COVID-19
• Código UNSPSC: 51201600
• NACRES: NA.26

Propriedades

• recombinante: expressed in E. coli
• Nível de qualidade: 100
• forma: liquid
• peso molecular: ≤72 kDa
• condição de armazenamento: avoid repeated freeze/thaw cycles
• técnica(s): ELISA: suitable
• Condições de expedição: dry ice

Descrição

Descrição geral

SARS-CoV-2 Nucleoprotein (aa 1-419) Recombinant Antigen, expressed in E. coli, Cat. No. AGX814 is for use in ELISA.

Descrição-alvo

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the virus strain severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. A SARS-CoV-2 nucleoprotein antigen can be used to support the detection of SARS-CoV-2 (COVID-19, 2019-nCoV).

forma física

Purified protein in 25mM Tris-HCl without preservatives, pH 8.0.

Reconstituição

Please refer to guidance on suggested starting dilutions and/or titers per application and sample type.

Armazenamento e estabilidade

Stable for 1 year at -10°C to -25°C from date of receipt. Avoid repeated freeze/thaw cycles.

Exoneração de responsabilidade

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Informações de segurança

• Código de classe de armazenamento: 12 - Non Combustible Liquids
• Classe de risco de água (WGK): nwg
• Ponto de fulgor (°F): Not applicable
• Ponto de fulgor (°C): Not applicable